| Long-term patency of autogenous saphenous veins vs. PTFE interposition graft for prosthetic hemodialysis access | Barçın ÖZÇEM,Kamil GÜLŞEN,Levent CERİT,Cenk CONKBAYIR | 0–0 |
| Thrombus aspiration in patients with ST elevation myocardial infarction: Meta-analysis of 16 randomized trials | İBRAHİM HALİL TANBOĞA,Selim TOPÇU,ENBİYA AKSAKAL,Mustafa KURT,AHMET KAYA,Vecih ODUNCU,SERDAR SEVİMLİ | 175–187 |
| Effect of cardiac resynchronization therapy on ventricular repolarization: A meta-analysis | Wei Xu Duan GAO | 188–195 |
| Evaluation of association between common genetic variants on hromosome 9p21 and coronary artery disease in Turkish population | Hüseyin Altuğ ÇAKMAK,BURCU BAYOĞLU,Eser DURMAZ,GÜNAY CAN,Bilgehan KARADAĞ,MÜJGAN CENGİZ,Vural Ali VURAL,Hüsniye YÜKSEL | 196–203 |
| The role of the fragmented QRS complexes on a routine 12-lead ECG in predicting non-responsiveness to cardiac resynchronization therapy | Mohammad Assadian RAD,Narges Tabarzan BABOLİ,Anoosh BARZİGAR,Jalal KEİRKHAH,Soheil SOLTANİPOUR,Hamid Reza BONAKDAR,Fardin MİRBOLOUK,Hassan MOLADOUST | 204–208 |
| The importance of fragmented QRS in the early detection of cardiac involvement in patients with systemic sclerosis | Nermin BAYAR,Hasan Fatih ÇAY,Zehra ERKAL,İLHAN SEZER,ŞAKİR ARSLAN,GÖKSEL ÇAĞIRCI,Serkan ÇAY,İsa Öner YÜKSEL,ERKAN KÖKLÜ | 209–212 |
| Predicting the outcome in patients with unexplained syncope and suspected cardiac cause: Role of electrophysiologic studies | Mohammad Assadian RAD,Mohammad FARAHANİ,Zahra EMKANJOO,Hassan MOLADOUST,Abolfath ALİZADEH | 213–217 |
| Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets | Fatih AKIN,Burak AYÇA,Ömer ÇELİK,CEM ŞAHİN | 218–223 |
| Epicardial adipose tissue thickness is associated with myocardial infarction and impaired coronary perfusion | Aslı TANINDI,Sinan Altan KOCAMAN,Aycan ERKAN FAHRİ,Murat UĞURLU,ASLIHAN ALHAN,Hasan Fehmi TÖRE | 224–231 |
| A clinical study about contrast nephropathy: Risk factors and the role of beta blockers | Çağdaş AKGÜLLÜ,UFUK ERYILMAZ,Hasan GÜNGÖR,MUSTAFA AHMET HUYUT,CEMİL ZENCİR,Tolga HEKİM | 232–240 |
| Contrast nephropathy: Risk factors and the role of beta blockers (Editorial Comment) | Rodney G. BOWDEN | 241–241 |
| Do we need a femoral artery route for transvenous PDA closure in children with ADO-I? | ALİ BAYKAN,NAZMİ NARİN,ABDULLAH ÖZYURT,Mustafa ARGUN,Özge PAMUKÇU,Sertaç H. ONAN,Sadettin SEZER,ZEYNEP BAYKAN,KAZIM ÜZÜM | 242–247 |
| Do we need a femoral artery route for transvenous PDA closure in children with ADO I? (Editorial Comment) | Basil THANOPOULOS (VASİLEİOS) | 248–248 |
| Six-minute walk test in pulmonary arterial hypertension | Rengin DEMİR,Mehmet Serdar KÜÇÜKOĞLU | 249–254 |
| QT interval variations and mortality risk: Is there any relationship? (Education) | Ciprian REZUŞ,Victor Dan MOGA,Anca OUATU,Mariana FLORİA | 255–258 |
| Catheter ablation of the anteroseptal accessory pathway from the non- coronary aortic cusp in a pediatric patient | İbrahim Cansaran TANIDIR,İsa ÖZYILMAZ,ALPER GÜZELTAŞ,Yakup ERGÜL,A. Serkan ÜNSAL | 259–260 |
| A complementary index for quantification of cardiac electrical dispersion: Transmural dispersion of repolarization | ÖMER YİĞİNER,Alptuğ TOKATLI,Namık ÖZMEN,Mehmet DOĞAN | 261–261 |
| A complementary index for quantification of cardiac electrical dispersion: Transmural dispersion of repolarization (Author`s Reply) | Juraj KUNİSEK | 261–262 |
| Heart rate variability can be affected by gender, blood pressure, and insulin resistance | Mustafa GÜLGÜN,MUZAFFER KÜRŞAT FİDANCI | 262–262 |
| Heart rate variability can be affected by gender, blood pressure, and insulin resistance (Author`s Reply) | MURTAZA EMRE DURAKOĞLUGİL | 263–263 |
| Long-term patency of autogenous saphenous veins vs. PTFE interposition graft for prosthetic hemodialysis access (Author`s Reply) | Adem İlkay DİKEN | 263–263 |
| The preanalytical and analytical factors responsible for false-positive cardiac troponins (To the Editor,) | KAAN OKYAY,AYLİN YILDIRIR | 264–265 |
| Cardiac enzyme (troponin levels) elevation in cardiac myxomas: Is it real? | Azin ALIZADEHASL,Anita SADEGHPOUR,Mohsen Neshati Pir BORJ | 264–264 |
| Acute anterior myocardial infarction after Bonzai use (To the Editor,) | SAMET YILMAZ,Sefa ÜNAL,MEVLÜT SERDAR KUYUMCU,Kevser Gülcihan BALCI,MUSTAFA MÜCAHİT BALCI | 265–266 |